SERINA THERAPEUTICS INC
SER·81751A108·US·Common Stock·Healthcare - Biotechnology-13D/G
SER (SERINA THERAPEUTICS INC) is held by 16 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($308,724), Waverly Advisors, LLC ($130,934), GEODE CAPITAL MANAGEMENT, LLC ($126,049). Net institutional sentiment: Bullish.
16
Holders
Avg rating(6 Elite)
$828,924
Total Value
71% (19)
Fund Consensus
10 buying - 4 selling
Who's Trading
InsiderBKBrannan Stephen K.Buy $2KJul 7, 2026
InsiderWJWILSON KAREN JBuy $9KJun 12, 2026
InsiderWJWILSON KAREN JBuy $9KJun 11, 2026
ActivistSISio Capital Management, LLC6.7%May 4, 2026
InsiderMRMoreadith RandallSell $19KMar 23, 2026
InsiderMRMoreadith RandallSell $98KMar 19, 2026
InsiderMRMoreadith RandallSell $23KJan 28, 2026
InsiderMRMoreadith RandallSell $7KJan 22, 2026
InsiderMRMoreadith RandallSell $6KJan 21, 2026
InsiderMRMoreadith RandallSell $6KJan 20, 2026
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer